{"id":290,"date":"2017-10-04T02:04:37","date_gmt":"2017-10-04T02:04:37","guid":{"rendered":"https:\/\/omnilegalgroup.com\/blog\/?p=290"},"modified":"2019-01-19T11:04:04","modified_gmt":"2019-01-19T11:04:04","slug":"allergan-finds-loophole-in-system-to-protect-patents-from-challengers","status":"publish","type":"post","link":"https:\/\/omnilegalgroup.com\/blog\/allergan-finds-loophole-in-system-to-protect-patents-from-challengers\/","title":{"rendered":"Allergan Finds Loophole in System to Protect Patents from Challengers"},"content":{"rendered":"

\"\"<\/a>Pharmaceutical giant, Allergan, may have found a loophole in the patent system to extend its monopoly over its drug, Restasis. Generic drugmakers sought to invalidate Allergan\u2019s patents on the dry eye medication in order to introduce generic, less expensive versions of the drug to consumers. These companies, led by Mylan, brought suit in district court as well as an inter partes review (IPR) proceeding before the U.S. Patent Trial and Appeal Board (PTAB), a process which makes patent challenges easier and less costly. In order to avoid IPR, which is simultaneously celebrated by patent challengers and loathed by drugmakers, Allergan transferred its patents to the New York Saint Regis Mohawk Tribe. The Tribe\u2019s status as a sovereign nation shields any patents it holds from IPR. In exchange for agreeing to exclusively license the patents back to the drug manufacturer, Allergan is to pay the Tribe $13.75 million upfront then $15 million per year thereafter in royalties. These figures pale in comparison to the $1.5 billion the drug brought in last year alone, accounting for 10% of Allergan\u2019s overall revenues.<\/span><\/p>\n

There is a concern this tactic could inhibit the entry of more affordable pharmaceuticals into the market. Indeed, four senators have asked the Senate Judiciary Committee to conduct an investigation into the agreement claiming it is \u201ca blatantly anti-competitive attempt to shield its patents from review and keep drug prices high.\u201d However, in a case against the University of Florida earlier this year, it was argued and decided that sovereign immunity applies not only to courts but also to quasi-judicial proceedings managed by the U.S. Patent and Trademark Office. Based on this precedent, Allergan has a solid argument as to the validity of its agreement with the Tribe. The only exception to a tribe\u2019s sovereign immunity is if Congress expressly abrogated it or the tribe itself expressly waives it. Nothing in the Patent Act abrogates such tribal immunity and the Tribe has made it clear they are definitely not waiving their immunity in this situation. <\/span><\/p>\n

Allergan responded to these concerns by stating the focus need not be on their agreement with the Saint Regis Mohawk Tribe but rather on the IPR process and \u201cits negative impact on life sciences.\u201d In long-term investment strategies, drug manufacturers find comfort in the protection of their patents. The threat of IPR creates significant business uncertainty rendering it far less attractive to expend vast resources to research and develop new pharmaceuticals. The Supreme Court will hear arguments this month as to the constitutionality of IPRs.<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"

Pharmaceutical giant, Allergan, may have found a loophole in the patent system to extend its monopoly over its drug, Restasis. Generic drugmakers sought to invalidate Allergan\u2019s patents on the dry eye medication in order to introduce generic, less expensive versions of the drug to consumers. These companies, led by Mylan, brought suit in district court…<\/p>\n","protected":false},"author":2,"featured_media":3194,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-290","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog"],"yoast_head":"\nAllergan Finds Loophole in System to Protect Patents from Challengers - Omni Legal Group Blog<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/omnilegalgroup.com\/blog\/allergan-finds-loophole-in-system-to-protect-patents-from-challengers\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Allergan Finds Loophole in System to Protect Patents from Challengers - Omni Legal Group Blog\" \/>\n<meta property=\"og:description\" content=\"Pharmaceutical giant, Allergan, may have found a loophole in the patent system to extend its monopoly over its drug, Restasis. Generic drugmakers sought to invalidate Allergan\u2019s patents on the dry eye medication in order to introduce generic, less expensive versions of the drug to consumers. These companies, led by Mylan, brought suit in district court...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/omnilegalgroup.com\/blog\/allergan-finds-loophole-in-system-to-protect-patents-from-challengers\/\" \/>\n<meta property=\"og:site_name\" content=\"Omni Legal Group Blog\" \/>\n<meta property=\"article:published_time\" content=\"2017-10-04T02:04:37+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2019-01-19T11:04:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/omnilegalgroup.com\/blog\/wp-content\/uploads\/2017\/10\/allergam.png\" \/>\n\t<meta property=\"og:image:width\" content=\"474\" \/>\n\t<meta property=\"og:image:height\" content=\"598\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Omid Khalifeh\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Omid Khalifeh\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/omnilegalgroup.com\\\/blog\\\/allergan-finds-loophole-in-system-to-protect-patents-from-challengers\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/omnilegalgroup.com\\\/blog\\\/allergan-finds-loophole-in-system-to-protect-patents-from-challengers\\\/\"},\"author\":{\"name\":\"Omid Khalifeh\",\"@id\":\"https:\\\/\\\/omnilegalgroup.com\\\/blog\\\/#\\\/schema\\\/person\\\/e88d4972c6e30001cc41817b64d35fa4\"},\"headline\":\"Allergan Finds Loophole in System to Protect Patents from Challengers\",\"datePublished\":\"2017-10-04T02:04:37+00:00\",\"dateModified\":\"2019-01-19T11:04:04+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/omnilegalgroup.com\\\/blog\\\/allergan-finds-loophole-in-system-to-protect-patents-from-challengers\\\/\"},\"wordCount\":431,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/omnilegalgroup.com\\\/blog\\\/allergan-finds-loophole-in-system-to-protect-patents-from-challengers\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/omnilegalgroup.com\\\/blog\\\/wp-content\\\/uploads\\\/2017\\\/10\\\/allergam.png\",\"articleSection\":[\"Blog\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/omnilegalgroup.com\\\/blog\\\/allergan-finds-loophole-in-system-to-protect-patents-from-challengers\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/omnilegalgroup.com\\\/blog\\\/allergan-finds-loophole-in-system-to-protect-patents-from-challengers\\\/\",\"url\":\"https:\\\/\\\/omnilegalgroup.com\\\/blog\\\/allergan-finds-loophole-in-system-to-protect-patents-from-challengers\\\/\",\"name\":\"Allergan Finds Loophole in System to Protect Patents from Challengers - Omni Legal Group Blog\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/omnilegalgroup.com\\\/blog\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/omnilegalgroup.com\\\/blog\\\/allergan-finds-loophole-in-system-to-protect-patents-from-challengers\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/omnilegalgroup.com\\\/blog\\\/allergan-finds-loophole-in-system-to-protect-patents-from-challengers\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/omnilegalgroup.com\\\/blog\\\/wp-content\\\/uploads\\\/2017\\\/10\\\/allergam.png\",\"datePublished\":\"2017-10-04T02:04:37+00:00\",\"dateModified\":\"2019-01-19T11:04:04+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/omnilegalgroup.com\\\/blog\\\/#\\\/schema\\\/person\\\/e88d4972c6e30001cc41817b64d35fa4\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/omnilegalgroup.com\\\/blog\\\/allergan-finds-loophole-in-system-to-protect-patents-from-challengers\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/omnilegalgroup.com\\\/blog\\\/allergan-finds-loophole-in-system-to-protect-patents-from-challengers\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/omnilegalgroup.com\\\/blog\\\/allergan-finds-loophole-in-system-to-protect-patents-from-challengers\\\/#primaryimage\",\"url\":\"https:\\\/\\\/omnilegalgroup.com\\\/blog\\\/wp-content\\\/uploads\\\/2017\\\/10\\\/allergam.png\",\"contentUrl\":\"https:\\\/\\\/omnilegalgroup.com\\\/blog\\\/wp-content\\\/uploads\\\/2017\\\/10\\\/allergam.png\",\"width\":474,\"height\":598},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/omnilegalgroup.com\\\/blog\\\/allergan-finds-loophole-in-system-to-protect-patents-from-challengers\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/omnilegalgroup.com\\\/blog\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Allergan Finds Loophole in System to Protect Patents from Challengers\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/omnilegalgroup.com\\\/blog\\\/#website\",\"url\":\"https:\\\/\\\/omnilegalgroup.com\\\/blog\\\/\",\"name\":\"Omni Legal Group Blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/omnilegalgroup.com\\\/blog\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/omnilegalgroup.com\\\/blog\\\/#\\\/schema\\\/person\\\/e88d4972c6e30001cc41817b64d35fa4\",\"name\":\"Omid Khalifeh\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/565923ffc8a80adddedf281a6f7f8052a83bed9b1506537aa4654cebd9b3097a?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/565923ffc8a80adddedf281a6f7f8052a83bed9b1506537aa4654cebd9b3097a?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/565923ffc8a80adddedf281a6f7f8052a83bed9b1506537aa4654cebd9b3097a?s=96&d=mm&r=g\",\"caption\":\"Omid Khalifeh\"},\"url\":\"https:\\\/\\\/omnilegalgroup.com\\\/blog\\\/author\\\/omid-khalifeh\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Allergan Finds Loophole in System to Protect Patents from Challengers - Omni Legal Group Blog","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/omnilegalgroup.com\/blog\/allergan-finds-loophole-in-system-to-protect-patents-from-challengers\/","og_locale":"en_US","og_type":"article","og_title":"Allergan Finds Loophole in System to Protect Patents from Challengers - Omni Legal Group Blog","og_description":"Pharmaceutical giant, Allergan, may have found a loophole in the patent system to extend its monopoly over its drug, Restasis. Generic drugmakers sought to invalidate Allergan\u2019s patents on the dry eye medication in order to introduce generic, less expensive versions of the drug to consumers. These companies, led by Mylan, brought suit in district court...","og_url":"https:\/\/omnilegalgroup.com\/blog\/allergan-finds-loophole-in-system-to-protect-patents-from-challengers\/","og_site_name":"Omni Legal Group Blog","article_published_time":"2017-10-04T02:04:37+00:00","article_modified_time":"2019-01-19T11:04:04+00:00","og_image":[{"width":474,"height":598,"url":"https:\/\/omnilegalgroup.com\/blog\/wp-content\/uploads\/2017\/10\/allergam.png","type":"image\/png"}],"author":"Omid Khalifeh","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Omid Khalifeh","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/omnilegalgroup.com\/blog\/allergan-finds-loophole-in-system-to-protect-patents-from-challengers\/#article","isPartOf":{"@id":"https:\/\/omnilegalgroup.com\/blog\/allergan-finds-loophole-in-system-to-protect-patents-from-challengers\/"},"author":{"name":"Omid Khalifeh","@id":"https:\/\/omnilegalgroup.com\/blog\/#\/schema\/person\/e88d4972c6e30001cc41817b64d35fa4"},"headline":"Allergan Finds Loophole in System to Protect Patents from Challengers","datePublished":"2017-10-04T02:04:37+00:00","dateModified":"2019-01-19T11:04:04+00:00","mainEntityOfPage":{"@id":"https:\/\/omnilegalgroup.com\/blog\/allergan-finds-loophole-in-system-to-protect-patents-from-challengers\/"},"wordCount":431,"commentCount":0,"image":{"@id":"https:\/\/omnilegalgroup.com\/blog\/allergan-finds-loophole-in-system-to-protect-patents-from-challengers\/#primaryimage"},"thumbnailUrl":"https:\/\/omnilegalgroup.com\/blog\/wp-content\/uploads\/2017\/10\/allergam.png","articleSection":["Blog"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/omnilegalgroup.com\/blog\/allergan-finds-loophole-in-system-to-protect-patents-from-challengers\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/omnilegalgroup.com\/blog\/allergan-finds-loophole-in-system-to-protect-patents-from-challengers\/","url":"https:\/\/omnilegalgroup.com\/blog\/allergan-finds-loophole-in-system-to-protect-patents-from-challengers\/","name":"Allergan Finds Loophole in System to Protect Patents from Challengers - Omni Legal Group Blog","isPartOf":{"@id":"https:\/\/omnilegalgroup.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/omnilegalgroup.com\/blog\/allergan-finds-loophole-in-system-to-protect-patents-from-challengers\/#primaryimage"},"image":{"@id":"https:\/\/omnilegalgroup.com\/blog\/allergan-finds-loophole-in-system-to-protect-patents-from-challengers\/#primaryimage"},"thumbnailUrl":"https:\/\/omnilegalgroup.com\/blog\/wp-content\/uploads\/2017\/10\/allergam.png","datePublished":"2017-10-04T02:04:37+00:00","dateModified":"2019-01-19T11:04:04+00:00","author":{"@id":"https:\/\/omnilegalgroup.com\/blog\/#\/schema\/person\/e88d4972c6e30001cc41817b64d35fa4"},"breadcrumb":{"@id":"https:\/\/omnilegalgroup.com\/blog\/allergan-finds-loophole-in-system-to-protect-patents-from-challengers\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/omnilegalgroup.com\/blog\/allergan-finds-loophole-in-system-to-protect-patents-from-challengers\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/omnilegalgroup.com\/blog\/allergan-finds-loophole-in-system-to-protect-patents-from-challengers\/#primaryimage","url":"https:\/\/omnilegalgroup.com\/blog\/wp-content\/uploads\/2017\/10\/allergam.png","contentUrl":"https:\/\/omnilegalgroup.com\/blog\/wp-content\/uploads\/2017\/10\/allergam.png","width":474,"height":598},{"@type":"BreadcrumbList","@id":"https:\/\/omnilegalgroup.com\/blog\/allergan-finds-loophole-in-system-to-protect-patents-from-challengers\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/omnilegalgroup.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Allergan Finds Loophole in System to Protect Patents from Challengers"}]},{"@type":"WebSite","@id":"https:\/\/omnilegalgroup.com\/blog\/#website","url":"https:\/\/omnilegalgroup.com\/blog\/","name":"Omni Legal Group Blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/omnilegalgroup.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/omnilegalgroup.com\/blog\/#\/schema\/person\/e88d4972c6e30001cc41817b64d35fa4","name":"Omid Khalifeh","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/565923ffc8a80adddedf281a6f7f8052a83bed9b1506537aa4654cebd9b3097a?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/565923ffc8a80adddedf281a6f7f8052a83bed9b1506537aa4654cebd9b3097a?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/565923ffc8a80adddedf281a6f7f8052a83bed9b1506537aa4654cebd9b3097a?s=96&d=mm&r=g","caption":"Omid Khalifeh"},"url":"https:\/\/omnilegalgroup.com\/blog\/author\/omid-khalifeh\/"}]}},"_links":{"self":[{"href":"https:\/\/omnilegalgroup.com\/blog\/wp-json\/wp\/v2\/posts\/290","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/omnilegalgroup.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/omnilegalgroup.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/omnilegalgroup.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/omnilegalgroup.com\/blog\/wp-json\/wp\/v2\/comments?post=290"}],"version-history":[{"count":1,"href":"https:\/\/omnilegalgroup.com\/blog\/wp-json\/wp\/v2\/posts\/290\/revisions"}],"predecessor-version":[{"id":3195,"href":"https:\/\/omnilegalgroup.com\/blog\/wp-json\/wp\/v2\/posts\/290\/revisions\/3195"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/omnilegalgroup.com\/blog\/wp-json\/wp\/v2\/media\/3194"}],"wp:attachment":[{"href":"https:\/\/omnilegalgroup.com\/blog\/wp-json\/wp\/v2\/media?parent=290"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/omnilegalgroup.com\/blog\/wp-json\/wp\/v2\/categories?post=290"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/omnilegalgroup.com\/blog\/wp-json\/wp\/v2\/tags?post=290"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}